Clinical Trial Update: Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the safety and feasibility of using allogeneic red blood cells loaded with L-asparaginase to treat relapsed acute lymphoblastic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Allogenic Red Blood Cells Loaded L-asparaginase (L-asparaginase-loaded allogeneic red blood cells)

Snippet

Sponsor: ERYtech Pharma | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED